21 results
8-K
bq35wj5g66xtmn
16 Jun 21
Satsuma Pharmaceuticals Announces Positive Pharmacokinetic, Tolerability and Safety Results From Phase 1 Trial of STS101 at Multiple Dose Strengths
4:29pm
8-K
EX-99.2
wnzxq qhds
1 Mar 21
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
12:00am
10-K
u5esdd7mi9zd
10 Mar 20
Annual report
4:20pm
10-Q
m8pd7km1nxo3gq5qsh0
12 Nov 19
Quarterly report
4:31pm
424B4
xfmick
13 Sep 19
Prospectus supplement with pricing info
5:08pm
S-1/A
1kc 9q6hb
3 Sep 19
IPO registration (amended)
6:12am
S-1
nmr172
16 Aug 19
IPO registration
5:15pm
DRS/A
0hd b2uomr9weu8xad
2 Aug 19
Draft registration statement (amended)
12:00am